Is a complete CAPR research report available?

No complete published report is available for Capricor Therapeutics, Inc. (CAPR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · USD

$6.21

+0.11 (+1.8%)· Recorded snapshot

Market cap	361M
Net income (ttm)	-129.4M
EPS (ttm)	-$2.47
Shares out	58.1M
Volume	2,733,100
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -129.4M
EPS (ttm): -$2.47
Market cap: 361M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001133869
Company name	Capricor Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	14070B309
Earnings date	2026-11-09
Earnings time	amc
Employees	231
Employees change	71
Employees growth	44.38%
Enterprise value	$214.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US14070B3096
Last 10-K release date	2026-03-17
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2019-06-05
Last stock split type	Reverse
Market cap	$361M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$6.21
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CAPR
U.S. state	California
Website	https://www.capricor.com

Metric

Value

Amount currency

USD

CIK code

0001133869

Company name

Capricor Therapeutics, Inc.

Country

United States

Country code

CUSIP number

14070B309

Earnings date

2026-11-09

Earnings time

amc

Employees

231

Employees change

Employees growth

44.38%

Enterprise value

$214.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2005

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US14070B3096

Last 10-K release date

2026-03-17

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2019-06-05

Last stock split type

Reverse

Market cap

$361M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$6.21

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CAPR

U.S. state

California

Website

https://www.capricor.com

Metric	Value
Earnings yield	-39.71%
FCF / EV yield	-60.93%
FCF yield	-36.06%
Forward EV/Sales	3.76x
Forward P/S	6.36x
P/B ratio	1.44x
Price / tangible book value	1.46x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-39.71%

FCF / EV yield

-60.93%

FCF yield

-36.06%

Forward EV/Sales

3.76x

Forward P/S

6.36x

P/B ratio

1.44x

Price / tangible book value

1.46x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-560,245
ROA	-33.63%
ROA (5Y)	-30.32%
ROCE	-40.25%
ROE	-73.7%
ROE (5Y)	-85.21%
ROIC	-38.11%

Metric

Value

Profit per employee

$-560,245

ROA

-33.63%

ROA (5Y)

-30.32%

ROCE

-40.25%

ROE

-73.7%

ROE (5Y)

-85.21%

ROIC

-38.11%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-25.8M
Depreciation and amortization	$2.1M
EBIT	$-135.2M
EBITDA	$-133.1M
EPS	$-2.47
FCF per share	$-2.23
Financing cash flow	$246M
Free cash flow	$-129.8M
Free cash flow minus SBC	$-149.6M
Gross profit	$-99.7M
Income taxes	$1,600
Investing cash flow	$-144.4M
Net cash flow	$-2.3M
Net income	$-129.4M
Operating cash flow minus SBC	$-123.8M
Operating income	$-135.2M
Stock-based compensation	$19.8M

Metric

Value

Capital expenditures

$-25.8M

Depreciation and amortization

$2.1M

EBIT

$-135.2M

EBITDA

$-133.1M

EPS

$-2.47

FCF per share

$-2.23

Financing cash flow

$246M

Free cash flow

$-129.8M

Free cash flow minus SBC

$-149.6M

Gross profit

$-99.7M

Income taxes

$1,600

Investing cash flow

$-144.4M

Net cash flow

$-2.3M

Net income

$-129.4M

Operating cash flow minus SBC

$-123.8M

Operating income

$-135.2M

Stock-based compensation

$19.8M

Metric	Value
Book value per share	$4.24
Debt / equity	0.37
Interest coverage	-44.38
Long-term assets	$126.6M
Long-term liabilities	$89.6M
Net cash (debt)	$146.9M
Net cash / market cap	40.82%
Net cash growth	20.64%
Net debt / equity	-0.6
Piotroski F-Score	2
Property, plant and equipment	$125M
Shareholders' equity	$246.2M
Tangible book value	$246.2M
Tangible book value per share	$4.24
Total assets	$368.7M
Total cash	$237.9M
Total debt	$91M
Total liabilities	$122.5M
WACC	6.59%

Metric

Value

Book value per share

$4.24

Debt / equity

0.37

Interest coverage

-44.38

Long-term assets

$126.6M

Long-term liabilities

$89.6M

Net cash (debt)

$146.9M

Net cash / market cap

40.82%

Net cash growth

20.64%

Net debt / equity

-0.6

Piotroski F-Score

Property, plant and equipment

$125M

Shareholders' equity

$246.2M

Tangible book value

$246.2M

Tangible book value per share

$4.24

Total assets

$368.7M

Total cash

$237.9M

Total debt

$91M

Total liabilities

$122.5M

WACC

6.59%

Metric	Value
Current assets	$242.1M
Current liabilities	$33M
Current ratio	7.35
Net working capital	$-27.3M
Quick ratio	7.22
Working capital	$209.2M

Metric

Value

Current assets

$242.1M

Current liabilities

$33M

Current ratio

7.35

Net working capital

$-27.3M

Quick ratio

7.22

Working capital

$209.2M

Metric	Value
Buyback yield / dilution	-24.2%
Dividend yield	0%
Shareholder yield	-24.2%

Metric

Value

Buyback yield / dilution

-24.2%

Dividend yield

Shareholder yield

-24.2%

Metric	Value
10Y price change	-80.29%
10Y return CAGR	-14.99%
10Y total return	-80.29%
150-day SMA	$19.11
1D price change	1.8%
1M price change	-26.2%
1M total return	-26.2%
1W price change	-6.66%
1W total return	-6.66%
1Y price change	-0.16%
1Y return CAGR	-0.16%
1Y total return	-0.16%
20-day SMA	$7.07
200-day SMA	$20.95
3M price change	-11.79%
3M total return	-11.79%
3Y price change	126.84%
3Y return CAGR	31.39%
3Y total return	126.84%
50-day SMA	$8.09
50-day SMA vs 200-day SMA	50under200
52-week high	$40.37
52-week high date	2025-12-03
52-week low	$2.96
52-week low date	2026-07-30
5Y price change	61.94%
5Y return CAGR	10.12%
5Y total return	61.94%
6M price change	-82.42%
6M total return	-82.42%
All-time high	$171.50
All-time high date	2014-01-22
All-time low	$0.88
All-time low date	2020-03-12
Average true range (ATR)	$0.63
Average volume	2.7M
Beta (1Y)	1.18
Beta (2Y)	2.18
Beta (5Y)	0.61
Change from 52-week high	-84.62%
Change from 52-week low	109.8%
Change from all-time high	-96.4%
Change from all-time low	601.14%
Change from open	3.33%
Day's gap	-1.48%
Dollar volume	$17M
High price	$6.41
Low price	$5.92
Monthly RSI	43.43
Open price	$6.01
Position in 52-week range	59.18%
Premarket change	-1.48%
Premarket close	$6.10
Premarket price	$6.01
Premarket volume	31.3K
Previous close	$6.10
Price vs 150-day SMA	-67.71%
Price vs 20-day SMA	-12.78%
Price vs 200-day SMA	-70.54%
Price vs 50-day SMA	-23.74%
Relative volume	1.01
RSI	38.09
Sharpe ratio	0.79
Sharpe ratio (3Y)	0.68
Sharpe ratio (5Y)	0.53
Sortino ratio	3.32
Sortino ratio (3Y)	2.21
Sortino ratio (5Y)	1.54
Volume	2.7M
Weekly RSI	33.1
YTD price change	-78.62%
YTD total return	-78.62%

Metric

Value

10Y price change

-80.29%

10Y return CAGR

-14.99%

10Y total return

-80.29%

150-day SMA

$19.11

1D price change

1.8%

1M price change

-26.2%

1M total return

-26.2%

1W price change

-6.66%

1W total return

-6.66%

1Y price change

-0.16%

1Y return CAGR

-0.16%

1Y total return

-0.16%

20-day SMA

$7.07

200-day SMA

$20.95

3M price change

-11.79%

3M total return

-11.79%

3Y price change

126.84%

3Y return CAGR

31.39%

3Y total return

126.84%

50-day SMA

$8.09

50-day SMA vs 200-day SMA

50under200

52-week high

$40.37

52-week high date

2025-12-03

52-week low

$2.96

52-week low date

2026-07-30

5Y price change

61.94%

5Y return CAGR

10.12%

5Y total return

61.94%

6M price change

-82.42%

6M total return

-82.42%

All-time high

$171.50

All-time high date

2014-01-22

All-time low

$0.88

All-time low date

2020-03-12

Average true range (ATR)

$0.63

Average volume

2.7M

Beta (1Y)

1.18

Beta (2Y)

2.18

Beta (5Y)

0.61

Change from 52-week high

-84.62%

Change from 52-week low

109.8%

Change from all-time high

-96.4%

Change from all-time low

601.14%

Change from open

3.33%

Day's gap

-1.48%

Dollar volume

$17M

High price

$6.41

Low price

$5.92

Monthly RSI

43.43

Open price

$6.01

Position in 52-week range

59.18%

Premarket change

-1.48%

Premarket close

$6.10

Premarket price

$6.01

Premarket volume

31.3K

Previous close

$6.10

Price vs 150-day SMA

-67.71%

Price vs 20-day SMA

-12.78%

Price vs 200-day SMA

-70.54%

Price vs 50-day SMA

-23.74%

Relative volume

1.01

RSI

38.09

Sharpe ratio

0.79

Sharpe ratio (3Y)

0.68

Sharpe ratio (5Y)

0.53

Sortino ratio

3.32

Sortino ratio (3Y)

2.21

Sortino ratio (5Y)

1.54

Volume

2.7M

Weekly RSI

33.1

YTD price change

-78.62%

YTD total return

-78.62%

Metric	Value
Float	45.5M
Float percentage	78.34%
Shares change (QoQ)	0.86%
Shares change (YoY)	24.2%
Shares held by insiders	0.93%
Shares held by institutions	61.1%
Shares outstanding	58.1M
Short % of float	41.33%
Short % of shares	32.38%
Short ratio	4.8 days

Metric

Value

Float

45.5M

Float percentage

78.34%

Shares change (QoQ)

0.86%

Shares change (YoY)

24.2%

Shares held by insiders

0.93%

Shares held by institutions

61.1%

Shares outstanding

58.1M

Short % of float

41.33%

Short % of shares

32.38%

Short ratio

4.8 days

Metric	Value
Page views	165

Metric

Value

Page views

165

Capricor Therapeutics, Inc. (CAPR)

Price

Financial snapshot

Fair-value bridge

Latest news · CAPR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CAPR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CAPR

Frequently asked questions